// company-profile
Xenon Pharmaceuticals Inc. Insider Trading
XENEEvery SEC Form 4 insider trading filing for Xenon Pharmaceuticals Inc. (XENE) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
curl "https://api.form4api.com/v1/transactions?ticker=XENE" -H "X-Api-Key: YOUR_API_KEY"// activity-summary
No insider transactions in the last 30 days.
// 90-day insight
Over the last 90 days, Xenon Pharmaceuticals Inc. insiders bought $26K (30 transactions) and sold $151K (2 transactions).
- Most active insider: GANNON STEVEN with 7 transactions totaling $101K.
- Largest single sale: $76K by Svoronos Dawn on Jun 1, 2026.
- 50% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Xenon Pharmaceuticals Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | PATOU GARY | XENE | Sale10b5 | 1,322 | $53.14 | $70K |
| Jun 5, 2026 | Cannon Gillian | XENE | Sale10b5 | 1,190 | $53.14 | $63K |
| Jun 3, 2026 | Machado Patrick | XENE | Award | 10,507 | $0.00 | $0K |
| Jun 3, 2026 | Gover Justin D. | XENE | Award | 1,593 | $0.00 | $0K |
| Jun 3, 2026 | PATOU GARY | XENE | Award | 10,507 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →